Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 3

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

University of Rochester · with National Cancer Institute (NCI) · NCT05006482

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 3
Target enrollment
668
US sites recruiting
44
Study start
March 21, 2023
Record last updated
January 13, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This phase III trial compares the effect of geriatric evaluation and management with survivorship health education (GEM-S) to usual care on patient-reported physical function in older survivors of cancer. Survivorship care for older adults of cancer usually consists of getting advice from their doctor. This advice may include how to do their daily activities, so they are less tired or how to manage multiple diseases, or long-term side effects from treatment. GEM-S may help improve the physical ability to perform activities of daily living, mental well-being, and memory in older survivors of cancer after chemotherapy. This study may help doctors learn if including GEM-S in their practices improves physical, mental and memory functions in their patients. The study may also help to understand how such care affects cancer patients and their caregivers' quality of life.

Being studied: Best Practice; Comprehensive Geriatric Assessment; Educational Intervention; Exercise Intervention; Questionnaire Administration; Tailored Intervention

Conditions: Lymphoma; Malignant Solid Neoplasm

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • PRACTICE CRITERIA: Participating practice clusters will be required to identify one (or more) oncologist and/or advanced practice practitioner (APPs; i.e., nurse practitioners, or physician assistants) as part of study eligibility. If another clinician is interested in participating, please contact University of Rochester Cancer Center (URCC) National Cancer Institute Community Oncology Research Program (NCORP) Research Base (RB) for approval
  • Oncologists/APPs/other clinicians must be licensed to practice
  • Oncologists/APPs/other clinicians must not have a plan to leave or retire from the NCORP practice within one year of enrolling into the study
  • PRACTICE CRITERIA: Support/buy-in from oncology physicians and/or APPs and/or other clinicians who are willing to participate in training and study procedures and enroll cancer survivors
  • ENTRY CRITERIA FOR ONCOLOGY PHYSICIANS/APPS/OTHER CLINICIANS: Oncology physicians/APPs/other clinicians must work at a participating site with no plans to leave that practice or retire within one year of enrollment into the study. We do not require that any or all oncology physicians and/or APPs at a practice setting agree to participate. Only one clinician is required for the practice cluster to be eligible. If another clinician (other than oncology physician or APP) is interested in participating, please contact URCC NCORP RB for approval
  • CANCER SURVIVORS: 65 years or older
  • CANCER SURVIVORS: Have completed or will have completed curative-intent treatment (e.g., surgery, chemotherapy, chemotherapy with radiation) for any solid tumor or lymphoma malignancy in last 6 months. If the survivor is receiving curative-intent chemotherapy, run-in study procedures can occur during the last 6 weeks of chemotherapy.
  • Cancer survivors who will receive or are receiving other treatments (e.g., hormonal treatment, monoclonal antibodies, immunotherapy, radiation) are eligible
  • For patients receiving neoadjuvant chemotherapy for curative intent, the run-in and baseline procedures can occur before or after surgery. Patients should be enrolled within 6 months from the end of surgery
  • CANCER SURVIVORS: Be willing and able to come in for study visits or willing to undergo informed consent and assessments remotely via tele-health visits
  • CANCER SURVIVORS: Be willing and able to provide informed consent and must sign consent in-person or remotely if it is not convenient or feasible to provide informed consent in-person
  • CANCER SURVIVORS: Speak and understand English and/or Spanish. Spanish-speaking cancer survivors are eligible as long as there are appropriate resources in place for completion of study procedures at the practice site. Registration for Spanish-speaking cancer survivors must be approved by the URCC NCORP Research Base after a phone call to determine the feasibility for the practice to enroll a Spanish-speaking participant
  • CAREGIVERS: 18 years or older
  • CAREGIVERS: Selected by the cancer survivor when asked if there is a "family member, partner, friend or caregiver (age 18 years or older) with whom you discuss or who can be helpful in health-related matters." A caregiver need not be someone who lives with the cancer survivor or provides direct hands-on care
  • CAREGIVERS: Speak and understand English and/or Spanish. Spanish-speaking caregivers are eligible as long as there are appropriate resources in place for completion of study procedures. Registration for Spanish-speaking caregivers must be approved by the URCC NCORP Research Base after a phone call to determine the feasibility for the practice to enroll a Spanish-speaking participant

Exclusion Criteria

  • CANCER SURVIVORS: Have a condition that precludes their ability to participate in informed consent or procedures (e.g., dementia)
  • CAREGIVERS: Caregivers unable to understand the informed consent form or study procedures due to cognitive, health, or sensory impairment will be excluded
  • Capacity to conduct informed consent procedures and study procedures will be determined by the coordinators in collaboration with the cancer survivors' oncologists. These procedures are similar to that of URCC 13070, which enrolled caregivers of older patients with advanced cancer

Recruiting US locations

  • Lewis and Faye Manderson Cancer Center

    Tuscaloosa, AL 35401

    Site contact: Site Public Contact · 800-338-2948

  • Kaiser Permanente-Fremont

    Fremont, CA 94538

    Site contact: Site Public Contact · 877-642-4691 · Kpoct@kp.org

  • Kaiser Permanente-San Francisco

    San Francisco, CA 94115

    Site contact: Site Public Contact · 877-642-4691 · Kpoct@kp.org

  • Helen F Graham Cancer Center

    Newark, DE 19713

    Site contact: Site Public Contact · 302-623-4450 · lbarone@christianacare.org

  • Medical Oncology Hematology Consultants PA

    Newark, DE 19713

    Site contact: Site Public Contact · 302-623-4450 · lbarone@christianacare.org

  • Hawaii Cancer Care Inc - Waterfront Plaza

    Honolulu, HI 96813

    Site contact: Site Public Contact · 808-524-6115 · i.webster@hawaiicancercare.com

  • Straub Clinic and Hospital

    Honolulu, HI 96813

    Site contact: Site Public Contact · 808-522-4333

  • Kapiolani Medical Center for Women and Children

    Honolulu, HI 96826

    Site contact: Site Public Contact · 808-983-6090

  • Tripler Army Medical Center

    Honolulu, HI 96859

    Site contact: Site Public Contact · 808-433-6336

  • Hawaii Cancer Care - Westridge

    ‘Aiea, HI 96701

    Site contact: Site Public Contact · 808-539-2273 · info@hawaiicancercare.com

  • Pali Momi Medical Center

    ‘Aiea, HI 96701

    Site contact: Site Public Contact · 808-486-6000

  • OSF Saint Anthony's Health Center

    Alton, IL 62002

    Site contact: Site Public Contact · 618-463-5623

  • Fairview Southdale Hospital

    Edina, MN 55435

    Site contact: Site Public Contact · 952-993-1517 · mmcorc@healthpartners.com

  • Hennepin County Medical Center

    Minneapolis, MN 55415

    Site contact: Site Public Contact · 952-993-1517 · mmcorc@healthpartners.com

  • Monticello Cancer Center

    Monticello, MN 55362

    Site contact: Site Public Contact · 952-993-1517 · mmcorc@healthpartners.com

  • Park Nicollet Clinic - Saint Louis Park

    Saint Louis Park, MN 55416

    Site contact: Site Public Contact · 952-993-1517 · mmcorc@healthpartners.com

  • Regions Hospital

    Saint Paul, MN 55101

    Site contact: Site Public Contact · 952-993-1517 · mmcorc@healthpartners.com

  • Lakeview Hospital

    Stillwater, MN 55082

    Site contact: Site Public Contact · 952-993-1517 · mmcorc@healthpartners.com

  • Rice Memorial Hospital

    Willmar, MN 56201

    Site contact: Site Public Contact · 952-993-1517 · mmcorc@healthpartners.com

  • Minnesota Oncology Hematology PA-Woodbury

    Woodbury, MN 55125

    Site contact: Site Public Contact · 952-993-1517 · mmcorc@healthpartners.com

  • Lake Regional Hospital

    Osage Beach, MO 65065

    Site contact: Site Public Contact · 573-302-2768 · clinicaltrials@lakeregional.com

  • Noyes Memorial Hospital/Myers Cancer Center

    Dansville, NY 14437

    Site contact: Site Public Contact · WCICTOresearch@urmc.rochester.edu

  • Northwell Health/Center for Advanced Medicine

    Lake Success, NY 11042

    Site contact: Site Public Contact · 516-734-8896

  • Highland Hospital

    Rochester, NY 14620

    Site contact: Site Public Contact · 585-341-8113

  • Pluta Cancer Center

    Rochester, NY 14623

    Site contact: Site Public Contact · 888-823-5923 · ctsucontact@westat.com

  • University of Rochester

    Rochester, NY 14642

    Site contact: Site Public Contact · 585-275-5830

  • Wilmot Cancer Institute at Webster

    Webster, NY 14580

    Site contact: Site Public Contact · WCICTOresearch@urmc.rochester.edu

  • Novant Health Breast Surgery - Greensboro

    Greensboro, NC 27403

    Site contact: Site Public Contact · 336-718-8335 · pjordan@novanthealth.org

  • Novant Health Cancer Institute - Kernersville

    Kernersville, NC 27284

    Site contact: Site Public Contact · 336-718-8335 · asmarrs@novanthealth.org

  • Novant Health Cancer Institute - Mount Airy

    Mount Airy, NC 27030

    Site contact: Site Public Contact · 336-718-8335 · asmarrs@novanthealth.org

  • Novant Health Cancer Institute - Statesville

    Stateville, NC 28625

    Site contact: Site Public Contact · 336-718-8335 · pjordan@novanthealth.org

  • Novant Health Cancer Institute - Thomasville

    Thomasville, NC 27360

    Site contact: Site Public Contact · 336-718-8335 · pjordan@novanthealth.org

  • Novant Health Forsyth Medical Center

    Winston-Salem, NC 27103

    Site contact: Site Public Contact · 336-718-8335 · pjordan@novanthealth.org

  • South Central Medical and Resource Center

    Lindsay, OK 73052

    Site contact: Site Public Contact · 405-756-1414

  • Geisinger Medical Center

    Danville, PA 17822

    Site contact: Site Public Contact · 570-271-5251 · HemonCCTrials@geisinger.edu

  • Geisinger Cancer Center Dickson City

    Dickson City, PA 18519

    Site contact: Site Public Contact · 877-204-6081 · hemoncctrials@geisinger.edu

  • Community Medical Center

    Scranton, PA 18510

    Site contact: Site Public Contact · 570-703-4768 · HemonCCTrials@geisinger.edu

  • Geisinger Wyoming Valley/Henry Cancer Center

    Wilkes-Barre, PA 18711

    Site contact: Site Public Contact · 570-271-5251 · HemonCCTrials@geisinger.edu

  • Chesapeake Regional Medical Center

    Chesapeake, VA 23320

    Site contact: Site Public Contact · CancerCare@ChesapeakeRegional.com

  • ThedaCare Regional Cancer Center

    Appleton, WI 54911

    Site contact: Site Public Contact · 920-364-3604 · ResearchDept@thedacare.org

  • Saint Vincent Hospital Cancer Center Green Bay

    Green Bay, WI 54301

    Site contact: Site Public Contact · 920-433-8889 · WI_research_admin@hshs.org

  • Saint Vincent Hospital Cancer Center at Saint Mary's

    Green Bay, WI 54303

    Site contact: Site Public Contact · 920-433-8889 · wi_research_admin@hshs.org

  • Marshfield Medical Center-River Region at Stevens Point

    Stevens Point, WI 54482

    Site contact: Site Public Contact · 800-782-8581 · oncology.clinical.trials@marshfieldresearch.org

  • Marshfield Medical Center - Weston

    Weston, WI 54476

    Site contact: Site Public Contact · 800-782-8581 · oncology.clinical.trials@marshfieldresearch.org

All healthy volunteers studies in Alabama →